Os melhores médicos para o tratamento de Cancro do fígado estádio 4 no exterior — Página 4

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

O Dr. Alexander Beny lidera o Serviço de Malignidades Gastrointestinais no Rambam Medical Center, especializando-se em casos avançados de câncer de fígado.

• Oncologista certificado com ampla formação em oncologia médica e radioterapia
• Diretor de serviços de oncologia gastrointestinal em um grande hospital israelense
• Concluiu treinamento especializado em técnicas modernas de braquiterapia
• Fluente em inglês e hebraico para pacientes internacionais

O Professor Lee Seok-gu é um cirurgião especialista em transplante de fígado no Hospital Myongji. Ele realizou cerca de 2.000 transplantes hepáticos. Alcançou o primeiro transplante de fígado sem transfusão na Coreia. Realizou o transplante de hepatócitos em um lactente de um mês de idade. Liderou o primeiro uso clínico de um fígado bioartificial para insuficiência hepática aguda. Também realizou transplantes com doador vivo no Egito e treinou equipes no Vietnã.

É Professor de Cirurgia no Hospital Myongji e ex-Diretor do Centro de Transplante de Órgãos no Samsung Medical Center. Obteve seu MD e MSc pela Universidade Nacional de Seul e seu PhD pela Universidade Católica da Coreia. Concluiu uma bolsa de pesquisa (fellowship) no Boston Children’s Hospital/Harvard e treinamento em transplantes na Johns Hopkins. Atuou como presidente de três sociedades nacionais em transplante e cirurgia pediátrica. Seus prêmios incluem o Chong Kun Dang Award, o Pfizer Clinical Medicine Award e o Astellas Investigator Award. Possui 447 publicações e 13 capítulos de livros.

Especialista em cirurgias oncológicas complexas, incluindo procedimentos de fígado, pâncreas e vias biliares nos hospitais Büyük Anadolu.

• Especialista em cirurgia oncológica com foco em cânceres gastrointestinais
• Realiza cirurgias bariátricas e metabólicas avançadas
• Experiente em operações de câncer de mama e tireoide

A Dra. Brenda Pastrana é uma cirurgiã oncológica certificada especializada em câncer de fígado no Hospital Galenia.

• Membro da Sociedade Mexicana de Oncologia
• Professora universitária na Universidad Anahuac desde 2020
• Título da Universidade Nacional Autônoma do México (UNAM)
• Formada como cirurgiã oncológica no Centro Medico Nacional 20 de Noviembre

A Prof. Elke Jaeger é uma oncologista de topo na Alemanha com 41 anos de experiência de experiência, especializada em cancro do fígado avançado na Clínica Nordwest.

• Chefe de Oncologia e Hematologia na Clínica Nordwest
• Realizou mais de 1.100 procedimentos oncológicos
• Listada entre os melhores oncologistas da Alemanha há 41 anos de experiência
• Professora de oncologia médica e hematologia
• Membro da Organização Europeia para a Investigação e Tratamento do Cancro (EORTC)

A Dra. Topcu formou-se no MD Anderson Cancer Center e especializa-se em cancro do fígado, entre outras áreas da oncologia. Traz uma vasta experiência internacional para a sua prática no Hospital Universitário Biruni.

• Oncologista médica certificada com mais de _doctor_9372_ anos de experiência
• Membro da Sociedade Europeia de Oncologia Médica (ESMO)
• Formada em centros oncológicos de referência nos EUA e no Canadá
• Especializada em cancros gastrointestinais complexos, incluindo cancro do fígado

O Dr. Atakan Topcu é oncologista médico no Hospital Medipol Acibadem District em Istambul. Especializa-se no tratamento de tumores sólidos, incluindo cancro do pulmão, da mama e colorretal. O Dr. Topcu é professor associado com mais de 50 publicações científicas revistas por pares. Faz parte do conselho editorial da revista médica BMC Cancer.

• Especialização em imunoterapia, terapias direcionadas e cuidados oncológicos geriátricos.
• Trata a desnutrição relacionada com o cancro, caquexia e sarcopenia.
• Membro ativo da Sociedade Europeia de Oncologia Médica (ESMO).
• Trabalha num hospital acreditado pela JCI, especializado em tratamentos oncológicos avançados.

A professora Gul Alco especializa-se em oncologia radioterápica no Hospital Medipol Acibadem, com mais de _doctor_7679_ anos de experiência na área.

• Professora no Departamento de Oncologia Radioterápica da Universidade Medipol de Istambul
• Concluiu a residência na Faculdade de Medicina da Universidade Kadir Has
• Professora associada e posteriormente professora na Universidade Demiroglu Bilim
• Trabalhou no Hospital Şişli Florence Nightingale e no Hospital Gayrettepe Florence Nightingale

A Dra. Ayşe İrem Yasin é oncologista médica no Hospital Distrital Medipol Acıbadem em Istambul. Ela possui o prestigioso certificado do conselho da ESMO. A Dra. Yasin é especializada em tumores sólidos, incluindo câncer de mama, pulmão e gastrointestinal. Ela trata casos complexos, como carcinoma de células de Merkel e cânceres de origem primária desconhecida.

• Formada na Harvard Medical School, Cleveland Clinic e no Hospital Universitário de Basileia.
• Concluiu um estágio clínico na Unidade de Câncer de Mama em Novara, Itália.
• Trata neoplasias malignas cerebrais e do SNC, sarcomas de tecidos moles e cânceres urológicos.
• Trabalha em uma instalação credenciada pela JCI equipada com o sistema robótico da Vinci.

Nail Paksoy traz uma vasta experiência do Instituto de Oncologia da Universidade de Istambul e atualmente atua como professor associado no Hospital Medipol Bahçelievler.

• Especializado no tratamento do câncer de fígado com foco em estágios avançados
• Certificado em Oncologia Médica pela ESMO
• Contribuiu para oito ensaios clínicos internacionais em oncologia
• Publicou vários artigos de pesquisa sobre cânceres metastáticos

O Dr. Kopchak é especializado em câncer de fígado, combinando a prática clínica com pesquisas de ponta no Instituto Nacional do Câncer.

• Mais de 30 artigos científicos publicados em periódicos indexados no Scopus
• Coautor de mais de 170 trabalhos de pesquisa e 2 monografias
• Pesquisador sênior em um importante instituto cirúrgico ucraniano
• Foca em estratégias de diagnóstico e tratamento cirúrgico

Com mais de _doctor_2687_anos_ de experiência cirúrgica, o Dr. Ugur Ekici, professor associado, é especializado em cirurgia laparoscópica avançada e cirurgia oncológica no Hospital Medicana Bahcelievler.

• Formação especializada na Clínica de Cirurgia Geral do Hospital Şişli Etfal
• Experiência em procedimentos oncológicos padrão e minimamente invasivos
• Pesquisas publicadas em revistas médicas internacionais

O Prof. Ersin Ozturk traz uma vasta experiência em oncologia cirúrgica e cirurgia gastrointestinal no Hospital Medicana Bursa.

• Professor de Medicina com mais de 28 anos de experiência de experiência
• Especializado em cirurgia laparoscópica e bariátrica
• Bolsa de pesquisa na Cleveland Clinic Foundation
• Membro de várias sociedades cirúrgicas

O Prof. Engin traz décadas de experiência especializada em oncologia radioterápica, incluindo formação avançada no National Cancer Institute e na Thomas Jefferson University.

• Ex-presidente de Oncologia Radioterápica na Universidade de Uludag
• Dirigiu programas de oncologia radioterápica em vários hospitais líderes
• Especializado em técnicas de termorradioterapia
• Detentor de bolsa de pesquisa do National Cancer Institute

O Dr. Sridhar P.S. é especializado em radioterapia para câncer de fígado no HCG Manavata Cancer Centre, com ampla formação em oncologia.

• Mais de _doctor_3397_ anos de experiência em radioterapia
• Diplomado pelo Conselho Nacional de Radioterapia
• Membro da Associação de Oncologia Radioterápica da Índia
• Especializado em neuro-oncologia e oncologia por hipertermia